Search results
Everything we know about King Charles' cancer, from diagnosis to treatment
TODAY via Yahoo News· 4 hours agoKing Charles III has just made his first public engagement at a London hospital since Buckingham...
Prostate cancer: Supplement, keto diet may boost immunotherapy
Medical News Today· 6 days agoAbout 13% of cisgender men around the world will receive a prostate cancer diagnosis in their...
No PSA Recurrence at 24 Months With Apalutamide Plus ADT After Radical Prostatectomy
MedPage Today· 4 days agoMore than 2 years after treatment, no patient with high-risk prostate cancer had a confirmed...
While battling Stage 4 cancer he lost it all in the Sulphur tornado
Oklahoma's NewsChannel 4· 3 days agoSteve Miller stepped over the wood debris on his property to speak with KFOR, it was his home, now...
Cancer scans delayed over supply issues - hospital
BBC via AOL· 3 days agoThe NHS trust said an alternative supplier had been found and it was working to clear the backlog. Terry Mott, 60, from Long Hanborough, Oxfordshire, was...
Can this thumb test tell if you are at increased risk of a hidden aortic aneurysm?
Medical Xpress· 3 days agoAn aneurysm is what we're referring to here. This is a ballooned segment of an artery—the vessels...
FibroGen, Inc. (NASDAQ:FGEN) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 day agoFibroGen, Inc. (NASDAQ:FGEN) Q1 2024 Earnings Call Transcript May 6, 2024 FibroGen, Inc. misses on...
Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines
NBC 10 - FOX 14 Monroe· 13 hours ago("Anixa" or the "Company") (NASDAQ: ANIX), a clinical-stage biotechnology company focused on the treatment and prevention of cancer, today announced that ...
Early onset bowel cancer cases increasing in New Zealand
Medical Xpress· 5 hours agoThe findings, published in BMC Cancer, show that while colorectal cancer rates (CRC) in older age groups have actually decreased (possibly in part due to ...
Phase 2 data for ERLEADA® (apalutamide) plus androgen deprivation therapy following radical...
WTNH-TV New Haven· 5 days agoJohnson & Johnson announced today results from the open-label, single-arm Phase 2 Apa-RP study...